Targepeutics Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 3

Targepeutics General Information

Description

Operator of a biopharmaceutical company intended to develop molecularly targeted therapeutics to fight cancer and other diseases. The company's services include drug discovery, research and development, and clinical design, enabling medical industry players to treat and destroy cancer cells with minimal normal cell damage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1214 Research Boulevard
  • Suite 1011
  • Hummelstown, PA 17036
  • United States
+1 (717)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Discovery Tools (Healthcare)
Corporate Office
  • 1214 Research Boulevard
  • Suite 1011
  • Hummelstown, PA 17036
  • United States
+1 (717)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Targepeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 24-Jul-2025 Completed Clinical Trials - Phase 3
2. Accelerator/Incubator 01-Mar-2023 Completed Clinical Trials - Phase 3
1. Grant 01-Jan-2022 $275K Completed Clinical Trials - Phase 3
To view Targepeutics’s complete valuation and funding history, request access »

Targepeutics Patents

Targepeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026050761-A1 Noninvasive tracking of a targeted toxin Pending 30-Aug-2024
JP-2026536310-A Hydrogel composition for the treatment of malignant glioma Pending 12-Oct-2023
AU-2024357719-A1 Hydrogel compositions for treatment of malignant gliomas Pending 12-Oct-2023
EP-4791435-A1 Hydrogel compositions for treatment of malignant gliomas Pending 12-Oct-2023
WO-2025081139-A1 Hydrogel compositions for treatment of malignant gliomas Inactive 12-Oct-2023 A61K38/2086
To view Targepeutics’s complete patent history, request access »

Targepeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Targepeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Yuvaan Tiwari Foundation Not-For-Profit Venture Capital Minority
National Institutes of Health Government
National Cancer Institute Government
To view Targepeutics’s complete investors history, request access »

Targepeutics FAQs

  • When was Targepeutics founded?

    Targepeutics was founded in 1997.

  • Where is Targepeutics headquartered?

    Targepeutics is headquartered in Hummelstown, PA.

  • What is the size of Targepeutics?

    Targepeutics has 5 total employees.

  • What industry is Targepeutics in?

    Targepeutics’s primary industry is Drug Discovery.

  • Is Targepeutics a private or public company?

    Targepeutics is a Private company.

  • What is Targepeutics’s current revenue?

    The current revenue for Targepeutics is .

  • Who are Targepeutics’s investors?

    Yuvaan Tiwari Foundation, National Institutes of Health, and National Cancer Institute have invested in Targepeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process